{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-018748","form_type":"8-K","ticker":"HCA","cik":"0000860730","company_name":"HCA Healthcare, Inc.","filed_at":"2024-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.072276+00:00","generated_at":"2026-06-06T15:32:42.504520+00:00","sec_items":["2.02","5.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"HCA Healthcare Q4 revenue up 11.6% to $17.3B; FY2024 EPS guidance $19.70-$21.20; CFO succession announced","bullets":["Q4 2023 revenue $17.303B (+11.6% YoY); net income $1.607B ($5.93 diluted EPS) vs $2.081B ($7.28) in Q4 2022, which included $1.326B gain.","Adjusted EBITDA $3.618B (up from $3.179B); same facility admissions +3.1%, equivalent admissions +3.9%.","FY2024 guidance: revenue $67.75-$70.25B, Adjusted EBITDA $12.85-$13.55B, diluted EPS $19.70-$21.20; capex $5.1-$5.3B.","Board authorized additional $6B share repurchase program; quarterly dividend declared at $0.66 per share (unchanged).","CFO Bill Rutherford retiring May 1, 2024; succeeded by Mike Marks, current SVP Finance."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-018748","json":"https://secwatch.observer/filing/0001193125-24-018748.json","markdown":"https://secwatch.observer/filing/0001193125-24-018748.md","text":"https://secwatch.observer/filing/0001193125-24-018748.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/860730/000119312524018748/0001193125-24-018748-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/860730/000119312524018748/d734797d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T15:32:42.504520+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5997dfe612424459e491d914208e7a0cd7e84c55","claim":"HCA Healthcare, Inc. reported 2024 results: revenue $67.75 to $70.25 billion, net income $5.20 to $5.60 billion, EPS $19.70 to $21.20 per diluted share. Guidance initiated.","evidence_excerpt":"Today, the Company issued the following estimated guidance for 2024: 2024 Guidance Range Revenues $67.75 to $70.25 billion Net Income Attributable to HCA Healthcare, Inc. $5.20 to $5.60 billion Adjusted EBITDA $12.85 to $13.55 billion EPS (diluted) $19.70 to $21.20 per diluted share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312524018748/0001193125-24-018748-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"2024"},{"label":"Revenue","value":"$67.75 to $70.25 billion"},{"label":"Net income","value":"$5.20 to $5.60 billion"},{"label":"EPS","value":"$19.70 to $21.20 per diluted share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"926c7c003adb0887ebea2f91545a3789e342009a","claim":"HCA Healthcare, Inc. reported the year ended December 31, 2023 results: revenue $64.968 billion, net income $5.242 billion, EPS $18.97 per diluted share. Guidance initiated.","evidence_excerpt":"Revenues for the year ended December 31, 2023 totaled $64.968 billion, compared to $60.233 billion for the year ended December 31, 2022. Net income attributable to HCA Healthcare, Inc. was $5.242 billion, or $18.97 per diluted share, for the year ended December 31, 2023 compared to $5.643 billion, or $19.15 per diluted share, for the year ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312524018748/0001193125-24-018748-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2023"},{"label":"Revenue","value":"$64.968 billion"},{"label":"Net income","value":"$5.242 billion"},{"label":"EPS","value":"$18.97 per diluted share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"b96bc48627b3edf3c2de7fcba1477654e49fb97a","claim":"HCA Healthcare, Inc. reported the fourth quarter ended December 31, 2023 results: revenue $17.303 billion, net income $1.607 billion, EPS $5.93 per diluted share. Guidance initiated.","evidence_excerpt":"Revenues in the fourth quarter of 2023 totaled $17.303 billion, compared to $15.497 billion in the fourth quarter of 2022. Net income attributable to HCA Healthcare, Inc. totaled $1.607 billion, or $5.93 per diluted share, compared to $2.081 billion, or $7.28 per diluted share, in the fourth quarter of 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312524018748/0001193125-24-018748-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2023"},{"label":"Revenue","value":"$17.303 billion"},{"label":"Net income","value":"$1.607 billion"},{"label":"EPS","value":"$5.93 per diluted share"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"4e2fb33af4","claim":"Michael A. Marks was appointed as Executive Vice President and Chief Financial Officer at HCA Healthcare, Inc..","evidence_excerpt":"On January 30, 2024, the Company announced that Michael A. Marks, age 54, will succeed Mr. Rutherford as Executive Vice President and Chief Financial Officer, effective May 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312524018748/0001193125-24-018748-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"e5a94bf734","claim":"William B. Rutherford retired as Executive Vice President and Chief Financial Officer at HCA Healthcare, Inc..","evidence_excerpt":"On January 24, 2024, William B. Rutherford notified the Company of his intent to retire from his position as Executive Vice President and Chief Financial Officer, effective May 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312524018748/0001193125-24-018748-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}